Cite
Subpopulation Differences in the Cardiovascular Efficacy of Long-Acting Glucagon-Like Peptide 1 Receptor Agonists in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis.
MLA
He, Liyun, et al. “Subpopulation Differences in the Cardiovascular Efficacy of Long-Acting Glucagon-Like Peptide 1 Receptor Agonists in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.” Diabetes Therapy, vol. 11, no. 9, Sept. 2020, pp. 2121–43. EBSCOhost, https://doi.org/10.1007/s13300-020-00882-2.
APA
He, L., Yang, N., Xu, L., Ping, F., Li, W., Li, Y., & Zhang, H. (2020). Subpopulation Differences in the Cardiovascular Efficacy of Long-Acting Glucagon-Like Peptide 1 Receptor Agonists in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis. Diabetes Therapy, 11(9), 2121–2143. https://doi.org/10.1007/s13300-020-00882-2
Chicago
He, Liyun, Na Yang, Lingling Xu, Fan Ping, Wei Li, Yuxiu Li, and Huabing Zhang. 2020. “Subpopulation Differences in the Cardiovascular Efficacy of Long-Acting Glucagon-Like Peptide 1 Receptor Agonists in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.” Diabetes Therapy 11 (9): 2121–43. doi:10.1007/s13300-020-00882-2.